openPR Logo
Press release

Global Nimodipine Market 2016 - Bayer, Uquifa, Shandong Health, Ruikang Pharma, Kelun Group, Xinhua Pharmaceutical, Yabao Group, Central Pharm

11-14-2016 12:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fior Markets

Global Nimodipine Market 2016 - Bayer, Uquifa, Shandong Health,

Nimodipine (marketed by Bayer as Nimotop) is a dihydropyridine calcium channel blocker originally developed for the treatment of high blood pressure. It is not frequently used for this indication, but has shown good results in preventing a major complication of subarachnoid hemorrhage (a form of cerebral hemorrhage) termed vasospasm.

Request for sample report at http://www.fiormarkets.com/report-detail/13588/request-sample

Because it has some selectivity for cerebral vasculature, nimodipine's main use is in the prevention of cerebral vasospasm and resultant ischemia, a complication of subarachnoid hemorrhage (a form of cerebral bleed), specifically from ruptured intracranial berry aneurysms irrespective of the patient's post-ictus neurological condition. Its administration begins within 4 days of a subarachnoid hemorrhage and is continued for three weeks. If blood pressure drops by over 5%, dosage is adjusted. There is still controversy regarding the use of intravenous nimodipine on a routine basis.

A 2003 trial (Belfort et al.) found nimodipine was inferior to magnesium sulfate in preventing seizures in women with severe preeclampsia. Nimodipine is not regularly used to treat head injury. Several investigations have been performed evaluating its use for traumatic subarachnoid hemorrhage; a systematic review of 4 trials did not suggest any significant benefit to the patients that receive nimodipine therapy.

This report provides detailed analysis of worldwide markets for Nimodipine from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Nimodipine market and further lays out an analysis of the factors influencing the supply/demand for Nimodipine, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Access full report at http://www.fiormarkets.com/report/global-nimodipine-market-outlook-2016-2021-13588.html

Global Nimodipine Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Nimodipine market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Nimodipine market are Bayer (Germany), Uquifa (Spain), Shandong Health (China), Ruikang Pharma (China), Kelun Group (China), Xinhua Pharmaceutical (China), Yabao Group (China), Central Pharm (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Nimodipine industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Nimodipine Market 2016 - Bayer, Uquifa, Shandong Health, Ruikang Pharma, Kelun Group, Xinhua Pharmaceutical, Yabao Group, Central Pharm here

News-ID: 382194 • Views: 391

More Releases from Fior Markets

Electric Boats and Ships Market 2019 Industry Dynamics - Akasol, Hinckley Yachts …
Recent market research study Global Electric Boats and Ships Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the
Automotive Service Market 2019 Industry Dynamics - Firestone Complete Auto Care, …
Recent market research study Global Automotive Service Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the market. The
Automotive and Transportation Connectors Market 2019 Industry Dynamics - TE Conn …
Recent market research study Global Automotive and Transportation Connectors Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the
Pet Veterinary Diets Market 2019 Industry Dynamics - Mars, Farmina Pet Foods, Ni …
Recent market research study Global Pet Veterinary Diets Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the market.

All 5 Releases


More Releases for Nimodipine

Nimodipine Market is Booming Worldwide (2020-2026)-Says QYResearch | , Sun Pharm …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Nimodipine Market Research Report 2020". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Nimodipine market. Players can use the accurate market facts and figures and statistical
Nimodipine Market Size to Rapid Growth and Forecast till 2025 | with Sun Pharm I …
The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Nimodipine market. It sheds light on how the global Nimodipine Market is expected to grow during the course of the forecast period. With SWOT analysis and Porter’s Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Nimodipine market and different players operating therein.
Nimodipine Sales Market 2019 | Worldwide Market Outlook 2025 | Major Manufacture …
As per the latest research study published by Up Market Research, “Global Nimodipine Sales Market” is estimated to grow at a healthy CAGR % in the coming years. The research report showcases qualitative and quantitative estimations by the industry analysts. The report documents first-hand data, post verification from the industry experts along with each industry manufacturers by the market valuation. Nimodipine Sales Market report also gives an extensive analysis of
Global Nimodipine Sales Market - Industry Analysis, Size, Share, Growth, Trends, …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Nimodipine Sales Market Report 2017” to its report offerings. The report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nimodipine for these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1289586 The global Nimodipine market is valued at USD XX million in 2016 and
Global Nimodipine Market - Uquifa, Shandong Health, Kelun Group, Central Pharm
Global Nimodipine market Report offers decisive insights into the overall Nimodipine industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Nimodipine industry segments based on the type of applications, type of product Components and services, and different geographical regions. Nimodipine (marketed by Bayer as Nimotop) is a dihydropyridine calcium channel blocker originally developed for the treatment
Global Nimodipine Market 2016 Analysis and Forecast to 2021
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1088267-global-and-china-nimodipine-market-research-report-forecast-2017-2021 The Global and China Nimodipine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Nimodipine industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Nimodipine market study provides comprehensive data which